Immediate Impact
1 from Science/Nature 57 standout
Citing Papers
Therapeutic advances in rheumatoid arthritis
2024 Standout
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Works of Emi Yamada being referenced
Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan
2020
Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3)
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Emi Yamada | 77 | 174 | 54 | 83 | 82 | 31 | 430 | |
| Zhiping Hu | 19 | 29 | 10 | 25 | 47 | 31 | 510 | |
| Torge Rempe | 27 | 25 | 143 | 72 | 11 | 26 | 377 | |
| Yu‐Chun Chen | 17 | 70 | 22 | 59 | 52 | 35 | 509 | |
| Yang Shen | 13 | 88 | 13 | 21 | 5 | 36 | 496 | |
| Zhiyuan Guan | 9 | 60 | 23 | 59 | 16 | 36 | 476 | |
| Mengzhen Wang | 48 | 15 | 15 | 67 | 23 | 42 | 422 | |
| Manxia Wang | 22 | 24 | 79 | 27 | 14 | 52 | 415 | |
| Guan‐Ting Liu | 3 | 35 | 15 | 85 | 28 | 29 | 441 | |
| Yuji Sato | 28 | 83 | 22 | 45 | 19 | 27 | 487 | |
| Yanhong Wang | 15 | 46 | 74 | 47 | 12 | 34 | 476 |
All Works
Login with ORCID to disown or claim papers
Loading papers...